Wellness Center Usa (OTCMKTS:WCUI – Get Free Report) and GeneDx (NASDAQ:WGS – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.
Profitability
This table compares Wellness Center Usa and GeneDx’s net margins, return on equity and return on assets.
Get Wellness Center Usa alerts:
Risk and Volatility
Wellness Center Usa has a beta of 4.82, suggesting that its stock price is 382% more volatile than the S&P 500. Comparatively, GeneDx has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500.
Insider & Institutional Ownership
0.0% of Wellness Center Usa shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 15.7% of Wellness Center Usa shares are owned by insiders. Comparatively, 29.6% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Wellness Center Usa and GeneDx”s top-line revenue, earnings per share and valuation.
Wellness Center Usa has higher earnings, but lower revenue than GeneDx.
Analyst Recommendations
This is a summary of current ratings and target prices for Wellness Center Usa and GeneDx, as reported by MarketBeat.
GeneDx has a consensus target price of $104.13, indicating a potential downside of 11.95%. Given Wellness Center Usa’s higher probable upside, equities research analysts clearly believe Wellness Center Usa is more favorable than GeneDx.
Summary
GeneDx beats Wellness Center Usa on 8 of the 11 factors compared between the two stocks.
About Wellness Center Usa
(Get Free Report)
Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.
About GeneDx
(Get Free Report)
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Critical Review: GeneDx (NASDAQ:WGS) versus Wellness Center Usa (OTCMKTS:WCUI)
